Now showing items 1-2 of 2

    • Abin-Carriquiry, J. Andrés; Costa, Gustavo; Urbanavicius, Jessika; Cassels Niven, Bruce; Rebolledo-Fuentes, Marco; Wonnacott, Susan; Dajas, Federico (2008)
      Nicotinic acetylcholine receptor agonists are considered potential pharmacological agents for Parkinson's Disease treatment, due to their ability to improve experimental Parkinson symptomatology, reduce 3,4-dihydroxy-l-p ...
    • Iturriaga-Vásquez, Patricio; Carbone, Annalisa; García Beltrán, Olimpo; Livingstone, Phil D.; Biggin, Philip C.; Cassels Niven, Bruce; Wonnacott, Susan; Zapata Torres, Gerald; Bermudez, Isabel (American Society for Pharmacology and Experimental Therapy, 2010)
      The Erythrina alkaloids erysodine and dihydro-β-erythroidine (DHβE) are potent and selective competitive inhibitors of α4β2 nicotinic acetylcholine receptors (nAChRs), but little is known about the molecular determinants ...